Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:320532.
doi: 10.1155/2015/320532. Epub 2015 Oct 1.

Virological Mechanisms in the Coinfection between HIV and HCV

Affiliations
Review

Virological Mechanisms in the Coinfection between HIV and HCV

Maria Carla Liberto et al. Mediators Inflamm. 2015.

Abstract

Due to shared transmission routes, coinfection with Hepatitis C Virus (HCV) is common in patients infected by Human Immunodeficiency Virus (HIV). The immune-pathogenesis of liver disease in HIV/HCV coinfected patients is a multifactorial process. Several studies demonstrated that HIV worsens the course of HCV infection, increasing the risk of cirrhosis and hepatocellular carcinoma. Also, HCV might increase immunological defects due to HIV and risk of comorbidities. A specific cross-talk among HIV and HCV proteins in coinfected patients modulates the natural history, the immune responses, and the life cycle of both viruses. These effects are mediated by immune mechanisms and by a cross-talk between the two viruses which could interfere with host defense mechanisms. In this review, we focus on some virological/immunological mechanisms of the pathogenetic interactions between HIV and HCV in the human host.

PubMed Disclaimer

References

    1. Kim A. Y., Chung R. T. Coinfection with HIV-1 and HCV—A one-two punch. Gastroenterology. 2009;137(3):795–814. doi: 10.1053/j.gastro.2009.06.040. - DOI - PMC - PubMed
    1. Chen J. Y., Feeney E. R., Chung R. T. HCV and HIV co-infection: mechanisms and management. Nature Reviews Gastroenterology and Hepatology. 2014;11(6):362–371. doi: 10.1038/nrgastro.2014.17. - DOI - PMC - PubMed
    1. Sengupta S., Powell E., Kong L., Blackard J. T. Effects of HCV on basal and Tat-induced HIV LTR activation. PLoS ONE. 2013;8(6) doi: 10.1371/journal.pone.0064956.e64956 - DOI - PMC - PubMed
    1. Kong L., Maya W. C., Moreno-Fernandez M. E., et al. Low-level HIV infection of hepatocytes. Virology Journal. 2012;9, article 157 doi: 10.1186/1743-422x-9-157. - DOI - PMC - PubMed
    1. Ansari A. W., Schmidt R. E., Shankar E. M., Kamarulzaman A. Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus. Journal of Translational Medicine. 2014;12, article 341 doi: 10.1186/s12967-014-0341-8. - DOI - PMC - PubMed

Substances